Neurochange events - Company finances
|
EUR
|
2024
From: 2024-05-15
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 8,774 | 56,775 |
| Profit before tax | 958 | 199 |
| Net profit | 958 | 199 |
| Equity | 958 | 1,157 |
| Liabilities | 61 | 7,106 |
| Non-current assets | 0 | 0 |
| Current assets | 1,019 | 8,263 |
| Total assets | 1,019 | 8,263 |
|
Taxes paid
|
||
| STI taxes | - | 220 |
|
Financial indicators
|
||
| Revenue change y/y | - | +547.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 94.0% | 2.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 17.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.9% | 0.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.9% | 0.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 6.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Neurochange events - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-07-02 | 2024-07-31 | 64.50 |
Neurochange events - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-09-28 | 2026-09-29 | 1620.92 |
| 2026-09-01 | 2026-09-27 | 4.92 |
| 2026-08-31 | 2026-08-31 | 3055.1 |
| 2026-08-28 | 2026-08-30 | 3051.0 |
| 2026-06-05 | 2026-06-05 | 0.0 |
| 2026-06-04 | 2026-06-04 | 0.0 |
| 2026-06-02 | 2026-06-03 | 0.0 |
| 2026-06-01 | 2026-06-01 | 0.0 |
| 2026-05-31 | 2026-05-31 | 0.0 |
| 2026-05-29 | 2026-05-30 | 0.0 |
| 2026-05-28 | 2026-05-28 | 0.0 |
| 2026-05-26 | 2026-05-27 | 0.0 |
| 2026-05-25 | 2026-05-25 | 0.0 |
| 2026-05-22 | 2026-05-24 | 0.0 |
| 2026-05-20 | 2026-05-21 | 0.0 |
| 2026-05-19 | 2026-05-19 | 0.0 |
| 2026-05-18 | 2026-05-18 | 0.0 |
| 2026-05-17 | 2026-05-17 | 0.0 |
| 2026-05-14 | 2026-05-16 | 0.0 |
| 2026-05-13 | 2026-05-13 | 0.0 |
| 2026-05-12 | 2026-05-12 | 0.0 |
| 2026-05-11 | 2026-05-11 | 0.0 |
| 2026-05-10 | 2026-05-10 | 0.0 |
| 2026-05-08 | 2026-05-09 | 0.0 |
| 2026-05-06 | 2026-05-07 | 0.0 |
| 2026-05-03 | 2026-05-05 | 0.0 |
| 2026-05-01 | 2026-05-02 | 0.0 |
| 2026-04-29 | 2026-04-30 | 0.0 |
| 2026-04-28 | 2026-04-28 | 0.0 |
| 2026-04-27 | 2026-04-27 | 0.0 |
| 2026-04-26 | 2026-04-26 | 0.0 |
| 2026-04-24 | 2026-04-25 | 0.0 |
| 2026-04-23 | 2026-04-23 | 0.0 |
| 2026-04-22 | 2026-04-22 | 0.0 |
| 2026-04-20 | 2026-04-21 | 0.0 |
| 2026-04-17 | 2026-04-19 | 0.0 |
| 2026-04-15 | 2026-04-16 | 0.0 |
| 2026-04-14 | 2026-04-14 | 0.0 |
| 2026-04-13 | 2026-04-13 | 0.0 |
| 2026-04-12 | 2026-04-12 | 0.0 |
| 2026-04-10 | 2026-04-11 | 0.0 |
| 2026-04-09 | 2026-04-09 | 0.0 |
| 2026-04-08 | 2026-04-08 | 0.0 |
| 2026-03-31 | 2026-04-07 | 3978.95 |
| 2026-03-28 | 2026-03-30 | 3967.77 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Neurochange events, MB (code 306761759) is a Small partnership active in organisation of conventions and trade shows. In the latest financial year 2025, the company generated revenue of €56.8K, compared with €8.8K in 2024, which indicates a strong year-on-year expansion in turnover. Despite the higher revenue base, net profit declined to €199 from €958 a year earlier, and the profit margin narrowed to 0.3% in 2025. The business therefore grew materially in sales, but profitability remained very limited. On the balance sheet, total assets increased to €8.3K, while equity stood at €1.2K and liabilities at €7.1K. The equity ratio was 14.0% and debt-to-equity 6.14, showing that liabilities made up a significant part of financing. Asset turnover reached 6.87x, reflecting high revenue generation relative to the asset base. Return on equity was 17.2% and return on assets 2.4%, both supported by the very small balance sheet structure.